Delivery Order SPE2DB22D3501-SPE2DB25FWN22
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,988.76 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count). This firm fixed-price, competitively awarded contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.13 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-pack units). This competitively awarded, non-set-aside delivery order reflects firm fixed pricing and is scheduled for completion by July 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform fulfillment from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $1,299.63 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on July 21, 2025, with completion scheduled for July 22, 2025. This is a non-set-aside competitive award issued as a child delivery order under AmerisourceBergen's larger contract vehicle. The pharmaceutical product will be delivered to the company's distribution center in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $2,494.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (quantity: 3 units) on July 25, 2025, with completion targeted for July 28, 2025. This is a non-set-aside competitive award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a $2,169.97 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for Xulane 150-35 mcg/day contraceptive patches (3-count units). The contract is a firm fixed price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,341.69 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-count package) on July 23, 2025, with completion due July 24, 2025. This is an unset-aside, competitively awarded contract performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a transactional purchase of pharmaceutical products within AmerisourceBergen's existing federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,787.52 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count units) on July 24, 2025, with completion scheduled for July 25, 2025. This firm fixed-price delivery order was awarded without set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate...
- This is a $1,571.52 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has an ultimate completion date of June 13, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately one thousand dollars to Amerisourcebergen Drug Corporation for Xulane 150-35 mcg/day transdermal patches. The order was placed under an existing indefinite-delivery/indefinite-quantity contract vehicle and calls for delivery of the contraceptive patches to a facility in Conshohocken, Pennsylvania by August 3, 2023 to support the Agency's medical supply needs. Amerisourcebergen will serve as the prime...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $52,005.94 to AmerisourceBergen Drug Corp for Xulane 150-35mcg contraceptive patches. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 22, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was competed among all eligible vendors. This...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWN22Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,642.20 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day patches (quantity: 3) with a firm fixed price structure. The contract, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same municipality. This delivery order is a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply pharmaceuticals, vaccines, and medical supplies to military healthcare programs worldwide. The Xulane patch delivery exemplifies the routine pharmaceutical procurement executed under this expansive IDC framework, supporting the Defense Health Agency and other federal healthcare systems with critical pharmaceutical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/22/25 |